Mirae Asset Global Investments Co. Ltd. grew its holdings in STERIS plc (NYSE:STE – Free Report) by 30.8% in the 4th quarter, ...

STERIS (NYSE:STE – Get Free Report) had its target price upped by analysts at Piper Sandler from $260.00 to $265.00 in a ...

STERIS’ STE new acquisitions and partnerships ... In recent years, the company has made several large acquisitions. It purchased the surgical instrumentation, laparoscopic instrumentation ...

Intuitive Surgical's robotic devices are potential game changers for the healthcare industry. The company's business has been recovering well since experiencing a slowdown due to the pandemic.

Steris this week announced that its jury trial against its subsidiary Isomedix Operations ended in a mistrial. The trial began on Dec. 4, 2024, and involved a plaintiff’s claim that ethylene oxide ...

The jury trial ended in a mistrial, which could potentially be favorable for STERIS as it allows them to prepare for and possibly achieve a more favorable outcome in a retrial. Isomedix intends to ...

The global surgical lights market is highly competitive, with a diverse range of players competing based on product innovation, pricing, and distribution network. Key players in the market include ...

These include wearable technologies, additive and subtractive manufacturing for medical applications, biomimetics, surgical robotics, augmented/virtual/immersive technologies and environments, and ...